Stroke Trial, Recruiting (NCT07546864)

Stroke Trial, Recruiting NCT07546864 Sponsor: Hacettepe University Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07546864 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a stroke (either caused by a blocked blood vessel or a bleed in the brain)
You are 18 years of age or older
Your stroke happened between 3 and 12 months ago
You have some ability to move your arm, hand, and leg, meeting certain movement recovery levels (confirm with trial site)
You scored 24 or higher on a standard memory and thinking test called the MMSE (confirm with trial site)
You do not have serious problems with your vision, bones/joints, or other neurological conditions
You are not currently taking part in another research study
You are willing to voluntarily agree to take part in the study

Who may not be able to join:

You have poor coordination or serious health problems that would stop you from taking part in the activities involved
You have a specific type of language difficulty called Wernicke's aphasia, which affects understanding of speech
You have received Botox (botulinum toxin) injections in the last 3 months
You have a mental health condition that might affect your ability to participate, such as depression, ongoing psychiatric treatment, or low motivation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gokcen Akyurek, Associate Professor, Hacettepe University

Phone: +905546366542

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07546864

Sponsor: Hacettepe University

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +905546366542

More information: https://clinicaltrials.gov/study/NCT07546864

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a stroke (either caused by a blocked blood vessel or a bleed in the brain)
You are 18 years of age or older
Your stroke happened between 3 and 12 months ago
You have some ability to move your arm, hand, and leg, meeting certain movement recovery levels (confirm with trial site)
You scored 24 or higher on a standard memory and thinking test called the MMSE (confirm with trial site)
You do not have serious problems with your vision, bones/joints, or other neurological conditions
You are not currently taking part in another research study
You are willing to voluntarily agree to take part in the study

Who may not be able to join:

You have poor coordination or serious health problems that would stop you from taking part in the activities involved
You have a specific type of language difficulty called Wernicke's aphasia, which affects understanding of speech
You have received Botox (botulinum toxin) injections in the last 3 months
You have a mental health condition that might affect your ability to participate, such as depression, ongoing psychiatric treatment, or low motivation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hacettepe University

Registry

ClinicalTrials.gov

Start date

15 February 2026

Est. completion

15 May 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Fugl-Meyer Motor Assessment (FMA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov